BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19823826)

  • 1. Peroxisome proliferator-activated receptor gamma-dependent activity of indole ring-substituted 1,1-bis(3'-indolyl)-1-(p-biphenyl)methanes in cancer cells.
    Guo J; Chintharlapalli S; Lee SO; Cho SD; Lei P; Papineni S; Safe S
    Cancer Chemother Pharmacol; 2010 May; 66(1):141-50. PubMed ID: 19823826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through PPARgamma-dependent and PPARgamma-independent pathways.
    Chintharlapalli S; Papineni S; Safe S
    Mol Cancer Ther; 2006 May; 5(5):1362-70. PubMed ID: 16731770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathways.
    Vanderlaag K; Su Y; Frankel AE; Grage H; Smith R; Khan S; Safe S
    Breast Cancer Res Treat; 2008 May; 109(2):273-83. PubMed ID: 17624585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,1-Bis(3'-indolyl)-1-(p-substitutedphenyl)methanes are peroxisome proliferator-activated receptor gamma agonists but decrease HCT-116 colon cancer cell survival through receptor-independent activation of early growth response-1 and nonsteroidal anti-inflammatory drug-activated gene-1.
    Chintharlapalli S; Papineni S; Baek SJ; Liu S; Safe S
    Mol Pharmacol; 2005 Dec; 68(6):1782-92. PubMed ID: 16155208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through activation of c-jun N-terminal kinase.
    Lei P; Abdelrahim M; Cho SD; Liu S; Chintharlapalli S; Safe S
    Carcinogenesis; 2008 Jun; 29(6):1139-47. PubMed ID: 18460448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of bladder tumor growth by 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes: a new class of peroxisome proliferator-activated receptor gamma agonists.
    Kassouf W; Chintharlapalli S; Abdelrahim M; Nelkin G; Safe S; Kamat AM
    Cancer Res; 2006 Jan; 66(1):412-8. PubMed ID: 16397256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new class of peroxisome proliferator-activated receptor gamma (PPARgamma) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes.
    Qin C; Morrow D; Stewart J; Spencer K; Porter W; Smith R; Phillips T; Abdelrahim M; Samudio I; Safe S
    Mol Cancer Ther; 2004 Mar; 3(3):247-60. PubMed ID: 15026545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,1-bis(3'-indolyl)-1-(p-substituted phenyl)methanes decrease mitochondrial membrane potential and induce apoptosis in endometrial and other cancer cell lines.
    Hong J; Samudio I; Chintharlapalli S; Safe S
    Mol Carcinog; 2008 Jul; 47(7):492-507. PubMed ID: 18085536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,1-Bis(3'-indolyl)-1-(p-substitutedphenyl)methanes induce peroxisome proliferator-activated receptor gamma-mediated growth inhibition, transactivation, and differentiation markers in colon cancer cells.
    Chintharlapalli S; Smith R; Samudio I; Zhang W; Safe S
    Cancer Res; 2004 Sep; 64(17):5994-6001. PubMed ID: 15342379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-dependent activation of endoplasmic reticulum stress-mediated apoptosis in pancreatic cancer by 1,1-bis(3'-indoly)-1-(p-substituted phenyl)methanes.
    Lei P; Abdelrahim M; Cho SD; Liu X; Safe S
    Mol Cancer Ther; 2008 Oct; 7(10):3363-72. PubMed ID: 18852139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes induce apoptosis and inhibit renal cell carcinoma growth.
    York M; Abdelrahim M; Chintharlapalli S; Lucero SD; Safe S
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6743-52. PubMed ID: 18006776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes inhibit growth, induce apoptosis, and decrease the androgen receptor in LNCaP prostate cancer cells through peroxisome proliferator-activated receptor gamma-independent pathways.
    Chintharlapalli S; Papineni S; Safe S
    Mol Pharmacol; 2007 Feb; 71(2):558-69. PubMed ID: 17093136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer chemotherapy with indole-3-carbinol, bis(3'-indolyl)methane and synthetic analogs.
    Safe S; Papineni S; Chintharlapalli S
    Cancer Lett; 2008 Oct; 269(2):326-38. PubMed ID: 18501502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit ovarian cancer cell growth through peroxisome proliferator-activated receptor-dependent and independent pathways.
    Lei P; Abdelrahim M; Safe S
    Mol Cancer Ther; 2006 Sep; 5(9):2324-36. PubMed ID: 16985067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5,5'-Dibromo-bis(3'-indolyl)methane induces Kruppel-like factor 4 and p21 in colon cancer cells.
    Cho SD; Chintharlapalli S; Abdelrahim M; Papineni S; Liu S; Guo J; Lei P; Abudayyeh A; Safe S
    Mol Cancer Ther; 2008 Jul; 7(7):2109-20. PubMed ID: 18645021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of tumor-necrosis-factor-alpha induced endothelial cell activation by a new class of PPAR-gamma agonists. An in vitro study showing receptor-independent effects.
    CalabrĂ² P; Samudio I; Safe SH; Willerson JT; Yeh ET
    J Vasc Res; 2005; 42(6):509-16. PubMed ID: 16155367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-cyano-lup-1-en-3-oxo-20-oic acid, a cyano derivative of betulinic acid, activates peroxisome proliferator-activated receptor gamma in colon and pancreatic cancer cells.
    Chintharlapalli S; Papineni S; Liu S; Jutooru I; Chadalapaka G; Cho SD; Murthy RS; You Y; Safe S
    Carcinogenesis; 2007 Nov; 28(11):2337-46. PubMed ID: 17724373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-dependent activation of NR4A2 (Nurr1) by 1,1-bis(3'-indolyl)-1-(aromatic)methane analogs in pancreatic cancer cells.
    Li X; Lee SO; Safe S
    Biochem Pharmacol; 2012 May; 83(10):1445-55. PubMed ID: 22405837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor gamma-dependent activation of p21 in Panc-28 pancreatic cancer cells involves Sp1 and Sp4 proteins.
    Hong J; Samudio I; Liu S; Abdelrahim M; Safe S
    Endocrinology; 2004 Dec; 145(12):5774-85. PubMed ID: 15345676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p21 expression is induced by activation of nuclear nerve growth factor-induced Balpha (Nur77) in pancreatic cancer cells.
    Lee SO; Chintharlapalli S; Liu S; Papineni S; Cho SD; Yoon K; Safe S
    Mol Cancer Res; 2009 Jul; 7(7):1169-78. PubMed ID: 19584258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.